Newsroom | 14771 results

Sorted by: Latest

ResearchPhoto/Multimedia
-

Radiant Expands Manufacturing to Scale Commercial Microreactor Production

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Radiant, the company building the world’s only plug-in-ready, transportable commercial nuclear microreactor, today announced an expansion of its U.S. manufacturing footprint to advance its Kaleidos microreactor into commercial production and deployment. The expansion includes a new headquarters and manufacturing facility in El Segundo, California — where Radiant will assemble its first commercial reactors for delivery beginning in 2028 — coupled with the cont...
-

Scientific Research and Virtual Universes Reveal the Secrets of the Lighthouse of Alexandria

PARIS--(BUSINESS WIRE)--More than 2,000 years after it was built, the legendary lighthouse of Alexandria is being brought back to life through scientific research and the use of virtual universes. For the first time, a scientifically complete 3D reconstruction reveals how one of the Seven Wonders of the World was built.Rising some 100 meters above the Mediterranean, this masterpiece of civil engineering dominated the coastline for nearly 16 centuries and withstood 18 earthquakes before its light...
-

GE HealthCare’s Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based magnetic resonance imaging (MRI) contrast agent (MBCA). If approved, MBCAs could offer an alternative to – or even replace – gadolinium-based contrast agents (GBCAs), the current standard of care. This is...
-

Sonic Incytes Announces Multi-Year Partnership with Madrigal Pharmaceuticals to Advance Non-Invasive Liver Assessment in MASH

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sonic Incytes Medical Corp., developer of the Velacur™ point-of-care liver assessment platform, today announced a multi-year partnership with Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for MASH, to advance the assessment and risk stratification of patients with or at risk for MASH. “MASH remains significantly underdiagnosed, and too many patients are missed or identified only a...
-

Samenvatting: Scientist.com lanceert Pharma Observatory, een agent-first marktinformatieplatform voor biofarma-R&D

SOLANA BEACH, Calif.--(BUSINESS WIRE)--Scientist.com, het toonaangevende AI-enabled R&D-orkestratieplatform en de marktplaats voor de sector van biowetenschappen, kondigde vandaag de lancering aan van Pharma Observatory, een marktinformatieplatform dat biofarmateams laat zien waar hun programma's in de ruimere markt zitten. Scientist.com helpt onderzoeksteams om een project wind in de zeilen te geven. Pharma Observatory plaatst dat project in context: wie werkt er nog aan die zelfde target...
-

Resumen: Scientist.com lanza Pharma Observatory, una plataforma de inteligencia de mercado centrada en los agentes de I+D del sector biofarmacéutico

SOLANA BEACH, California--(BUSINESS WIRE)--Scientist.com, la plataforma líder de coordinación de I+D con tecnología de IA y mercado para el sector de las ciencias de la vida, ha anunciado hoy el lanzamiento de Pharma Observatory, una plataforma de inteligencia de mercado que muestra a los equipos biofarmacéuticos cuál es la posición de sus programas en el mercado general. Scientist.com ayuda a los equipos de investigación a impulsar un proyecto. Pharma Observatory sitúa ese proyecto en su conte...
-

Scientist.com startet „Pharma Observatory“, eine agentenorientierte Marktinformationsplattform für die biopharmazeutische Forschung und Entwicklung

SOLANA BEACH, Kalifornien--(BUSINESS WIRE)--Scientist.com, die führende KI-gestützte Plattform zur Koordination von Forschung und Entwicklung sowie Marktplatz für die Life-Science-Branche, gab heute die Einführung von „Pharma Observatory“ bekannt, einer Marktinformationsplattform, die Biopharma-Teams aufzeigt, wo sich ihre Programme im Gesamtmarkt positionieren. Scientist.com unterstützt Forschungsteams dabei, ein Projekt voranzutreiben. „Pharma Observatory“ ordnet dieses Projekt in einen Konte...
-

Riassunto: Scientist.com lancia Pharma Observatory, una piattaforma di intelligence del mercato incentrata sugli agenti per la ricerca e lo sviluppo nel settore biofarmaceutico

SOLANA BEACH, Calif.--(BUSINESS WIRE)--Scientist.com, la principale piattaforma di orchestrazione R&S abilitata all'AI del settore delle scienze della vita, nonché mercato per prodotti e servizi scientifici, oggi ha annunciato il lancio di Pharma Observatory, una piattaforma di intelligence di mercato che mostra ai team operanti nel settore biofarmaceutico la collocazione dei propri programmi nel mercato più ampio. Scientist.com aiuta i team di ricerca a portare avanti un progetto. Pharma O...
-

Scientist.com lance Pharma Observatory, une plateforme d’intelligence de marché axée sur les agents pour le secteur de la R&D biopharmaceutique

SOLANA BEACH, Californie--(BUSINESS WIRE)--Scientist.com, plateforme leader d’orchestration de la R&D et place de marché alimentée par l’IA pour le secteur des sciences de la vie, a annoncé aujourd’hui le lancement de Pharma Observatory, une plateforme d’intelligence de marché qui permet aux équipes biopharmaceutiques d’évaluer le positionnement de leurs programmes par rapport à l’ensemble du marché. Scientist.com aide les équipes de recherche à faire avancer leurs projets. Pharma Observato...
-

Aterio Satellite Analysis Shows Construction Underway at SB Energy's PORTS Technology Campus in Ohio

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aterio, an alternative data provider tracking U.S. infrastructure development, today reported that early site work has begun at SB Energy's PORTS Technology Campus in Pike County, Ohio. Planet satellite imagery shows land clearing near the first two planned building footprints, and Ohio EPA records list two active construction stormwater permits issued on November 2 and November 4, 2026, covering 34.4 and 7.59 acres. Aterio estimates the first two P...